Work overview

Section 04 of 37

DEFINITION OF PROBIOTICS

Mechanistic insights into probiotic modulation of the gut–immune axis and their role as sustainable antibiotic alternatives in poultry production: An integrative review

Andreas Berny Yulianto, Aswin Rafif Khairullah, Widya Paramita Lokapirnasari, Mohammad Anam Al-Arif, Zulfi Nur Amrina Rosyada, Emy Koestanti Sabdoningrum, Bodhi Agustono, Mirni Lamid, Kartika Purnamasari, Bima Putra Pratama, Riza Zainuddin Ahmad, Wasito Wasito, Saifur Rehman, and Muhammad Aviv Firdaus · 2026

Contents

Section 04 of 37

  1. 01INTRODUCTION
  2. 02REVIEW METHODOLOGY
  3. 03BASIC CONCEPTS OF PROBIOTICS IN POULTRY
  4. 04DEFINITION OF PROBIOTICS
  5. 05TYPES AND SOURCES OF PROBIOTICS FOR POULTRY
  6. 06STRAIN-SPECIFIC EFFECTS AND QUANTITATIVE EVIDENCE
  7. 07GENERAL MECHANISMS OF PROBIOTICS IN THE DIGESTIVE TRACT
  8. 08IMMUNE SYSTEM IN POULTRY
  9. 09MUCOSAL IMMUNITY (GALT)
  10. 10INNATE IMMUNITY
  11. 11ADAPTIVE IMMUNITY
  12. 12GUT–IMMUNE AXIS RELATIONSHIP IN POULTRY
  13. 13THE EFFECT OF PROBIOTICS ON POULTRY IMMUNITY
  14. 14PROBIOTICS IN INCREASING INNATE IMMUNITY
  15. 15PROBIOTICS AND ADAPTIVE IMMUNITY
  16. 16EFFECTS ON MAJOR IMMUNE ORGANS
  17. 17PROBIOTICS IN REDUCING STRESS AND INFLAMMATION
  18. 18PROBIOTIC–MICROBIOTA INTERACTIONS IN SUPPORTING IMMUNITY
  19. 19THE EFFECT OF PROBIOTICS ON DISEASE RESISTANCE IN POULTRY
  20. 20FACTORS THAT INFLUENCE THE SUCCESS OF PROBIOTICS
  21. 21DOSAGE AND DURATION OF ADMINISTRATION
  22. 22DOSAGE FORM
  23. 23STABILITY AND RESISTANCE TO PH AND TEMPERATURE
  24. 24COMBINATION WITH PREBIOTICS (SYNBIOTICS)
  25. 25BACTERIAL STRAINS USED
  26. 26IN OVO AND EARLY-LIFE PROBIOTIC ADMINISTRATION
  27. 27CHALLENGES AND LIMITATIONS OF PROBIOTIC USE
  28. 28IMPLICATIONS FOR THE POULTRY INDUSTRY
  29. 29MARKET TRENDS AND REGIONAL ADOPTION PATTERNS
  30. 30SHORT-TERM APPLICABLE STRATEGIES FOR INDUSTRY IMPLEMENTATION
  31. 31ILLUSTRATIVE COMMERCIAL CASE EXAMPLES
  32. 32LONG-TERM RESEARCH AND DEVELOPMENT GOALS
  33. 33EMERGING ANALYTICAL APPROACHES
  34. 34FURTHER RESEARCH DIRECTIONS
  35. 35CONCLUSION
  36. 36GENERATIVE ARTIFICIAL INTELLIGENCE DECLARATION
  37. 37AUTHORS’ CONTRIBUTIONS
Text size
Work overview

Section 4 of 37

DEFINITION OF PROBIOTICS

Andreas Berny Yulianto, Aswin Rafif Khairullah, Widya Paramita Lokapirnasari, Mohammad Anam Al-Arif, Zulfi Nur Amrina Rosyada, Emy Koestanti Sabdoningrum, Bodhi Agustono, Mirni Lamid, Kartika Purnamasari, Bima Putra Pratama, Riza Zainuddin Ahmad, Wasito Wasito, Saifur Rehman, and Muhammad Aviv Firdaus · about 2 minutes

Scientifically, probiotics are defined as live microorganisms that can provide health benefits to the host when consumed in adequate amounts [23]. Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer health benefits on the host, and in poultry, they are primarily used to improve gut microbiota balance and modulate the avian immune system [24]. Thus, probiotics not only act as commensal microbes but are active organisms that have been experimentally shown to produce physiological effects on the host, such as modulating the immune system, improving intestinal function and integrity, and inhibiting the growth of pathogens [25].

Conceptually, the definition of probiotics encompasses several fundamental scientific aspects. First, probiotics must consist of living microorganisms, namely cells that can survive until they reach the digestive tract and continue their biological activity [26]. This viability is assessed by the microbe's ability to withstand extreme conditions, including gastric pH, bile salts, and other gastrointestinal conditions [27]. Second, the effects of probiotics are dose-dependent, so they must be administered in sufficient quantities [28]. Various studies have shown that the effective dose range is between 10⁶ and 10¹⁰ colony-forming units (CFU), depending on the strain and the intended use [29].

The third important aspect is that the benefits of probiotics are strain-specific [30]. This means that each strain of microorganism has different genetic characteristics, colonization abilities, and physiological effects [31]. Therefore, claims of probiotic effectiveness cannot be generalized at the genus or species level but must be proven for each strain [32]. Fourth, probiotics must have a verified safety profile, including not carrying potentially transferable AMR genes (ARGs), not producing toxins, and not exhibiting pathogenic properties [33]. This safety assessment refers to the Generally Recognized as Safe (GRAS) or Qualified Presumption of Safety (QPS) systems used in evaluating microorganisms for feed and food applications [34].

In the context of poultry, probiotics are defined as microorganisms that not only improve gastrointestinal health but also modulate the immune system, enhance vaccine responses, and suppress the colonization of pathogens such as Salmonella, Escherichia coli, and Clostridium spp. [35]. Thus, probiotics function as biological agents that help maintain gastrointestinal balance and enhance the performance of the poultry immune system through mechanisms involving interactions among the gut microbiota, the intestinal epithelium, and the GALT [36].